Study challenges long-held fears about overactive bladder drugs and dementia
New research published in JAMA Network Open finds anticholinergic medications, commonly prescribed for overactive bladder (OAB), may not increase dementia risk after all compared to beta-3 agonists, the newer drug class that has been presumed to be safer for the brain.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Two-year study will examine how gender-affirming hormone therapy affects energy use and blood vessel function
United Kingdom
-
Stanford study challenges long-held dogma on causes of concussions
United Kingdom
-
New monoclonal antibody therapy significantly lowers patient triglyceride levels
United Kingdom
-
Cluster headache linked to pronounced levels of burnout symptoms
United Kingdom
-
Could a daily supplement keep blood vessels healthier as we age?
United Kingdom
-
Why obesity affects males and females differently
United Kingdom
-
Your brain may map emotional concepts onto a hexagonal grid, new study suggests
United Kingdom
-
In phase 2 trial, novel therapy significantly reduced triglyceride levels
United Kingdom